University of Colorado Cancer Center
- Company typePrivate
- Founded1988
- HeadquartersAurora, United States
- Headcount10,001+
- GTM typeB2B and B2C
- OfferingServices
University of Colorado Cancer Center firmographics
Firmographics- Name
- University of Colorado Cancer Center
- Legal name
- University of Colorado Cancer Center
- Website
- https://medschool.cuanschutz.edu
- Company type
- Private
- Founded year
- 1988
- Operating status
- Operating
- Headcount range
- 10,001+ employees
- Ownership category
- akta.pro rank
University of Colorado Cancer Center industry classification
Industry- Product category
- Cancer Treatment and Research
- NAICS
- Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Other Outpatient Care Centers (62149), Colleges, Universities, and Professional Schools (6113), Medical Laboratories (621511)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000), Services-Medical Laboratories (8071)
- akta.pro industry
- Academic Medical Centers (AMCs) & Teaching HospitalsHospital-Integrated Cancer Centers (Acute Oncology Programs)Ambulatory Oncology Centers (Outpatient Chemo/Radiation)Medical OncologyClinical Research & Trial Central LaboratoriesPublic Research Universities with Academic Medical Centers (AMCs)
Keywords
Where University of Colorado Cancer Center is headquartered
LocationHeadquarters
- HQ city
- Aurora
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
University of Colorado Cancer Center business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Others
Revenue model
- Research Grants and Funding: The institution receives significant federal and private research funding including NIH grants ($655 million in research grants awarded in FY2025) and foundation awards for biomedical research.
- Patient Care Services: Clinical services provided through UCHealth system and affiliated hospitals generating revenue from medical procedures, treatments, and healthcare services.
- Education and Training Programs: Medical education programs including MD admissions, graduate medical education, and professional development courses for healthcare professionals.
Go-to-market motion1 record
Distribution channels4 records
Marketing channels5 records
University of Colorado Cancer Center product offering
Product offeringCore offering
The University of Colorado Cancer Center is an NCI-designated Comprehensive Cancer Center providing cancer diagnosis, treatment, and clinical trials to patients, alongside biomedical research and medical education programs. It operates as part of the CU Anschutz Medical Campus and is affiliated with UCHealth, Children's Hospital Colorado, Denver Health, and VA Eastern Colorado, conducting translational research, AI-driven diagnostics, and innovative therapies including FDA-cleared CAR T-cell therapy.
Product overview
University of Colorado Cancer Center (a part of CU Anschutz Medical Campus) offers comprehensive cancer care through integrated research, clinical trials, and treatment programs. The center provides AI-powered diagnostic tools including retinal screening for NICU patients, single-cell analytics for autoimmune disease research, and extensive clinical trial offerings. Supporting infrastructure includes regulatory compliance services (COMIRB, EHS, research committees) and privacy protection under HIPAA. The center collaborates across the CU Anschutz campus which includes schools of medicine, nursing, pharmacy, dental medicine, and public health.
Differentiator
Problem solved
Functional benefit
Products and services
- Cancer Treatment and Research Comprehensive cancer care including diagnosis, treatment, research, and clinical trials delivered through the NCI-designated Comprehensive Cancer Center at CU Anschutz Medical Campus.
- Clinical Trials Program Extensive portfolio of cancer clinical trials offering patients access to cutting-edge treatments and experimental therapies.
- AI-Based Retinopathy of Prematurity Screening AI algorithm for screening infants in the NICU for retinopathy of prematurity (ROP), classifying vascular severity on a 1-9 scale to help standardize diagnosis and predict treatment needs.
- Single-Cell Analytics Platform for Autoimmune Research AI-powered research platform using single-cell transcriptomics and spatial transcriptomics to identify patient subgroups and discover therapeutic targets for rheumatoid arthritis and autoimmune diseases.
- Colorado Multiple Institutional Review Board (COMIRB) Five institutional review boards (IRBs) for human subjects research review for CU Anschutz, CU Denver and affiliates including Children's Hospital Colorado, Denver Health, UCHealth, and VA Eastern Colorado.
- Environmental Health and Safety (EHS) Safety programs including biological safety, hazardous materials, occupational health, radiation safety, and research safety for CU Anschutz campus.
- Research Committees Regulatory oversight committees including IACUC (animal studies), IBC (biosafety), CIR (ionizing radiation), and RDRC (radioactive drug research).
- HIPAA Privacy Office Privacy protection services ensuring HIPAA compliance for patient health information across University of Colorado Denver and Anschutz medical campuses.
- Campus-Built CAR T-Cell Therapy First-in-U.S. FDA-cleared CAR T-cell therapy developed by the University of Colorado Anschutz Gates Institute, a groundbreaking cell therapy for blood cancer treatment.
- Comparative Oncology Training Program Comparative oncology course offered at Colorado State University's Flint Animal Cancer Center for CU Anschutz medical students, translating research on prevention, diagnosis, and treatment of naturally occurring cancer in pet animals to benefit both pets and people.
Quantifiable outcome
- First-in-U.S. FDA clearance for campus-built CAR T-cell therapy
- +3 more outcomes
Companies that use University of Colorado Cancer Center
Customer profileNamed customers6 records
Segments4 records
Ideal customer profiles4 records
University of Colorado Cancer Center technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability8 records
Feature3 records
University of Colorado Cancer Center partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered core and minor.
- Colorado State University (CSU) - Flint Animal Cancer CentercoreCollaborative comparative oncology research program where CU Anschutz medical students train at CSU's Flint Animal Cancer Center. FACC researchers including director Susan Lana, DVM are CU Anschutz Cancer Center members. The partnership focuses on translating research on prevention, diagnosis, and treatment of naturally occurring cancer in pet animals to benefit both pets and people.
- Oregon Health & Science UniversityminorCollaboration with CU Anschutz researchers Emily Cole, MD and Praveer Singh, PhD on smartphone-based telescreening for retinopathy of prematurity (ROP). Tested cost-effective alternatives to expensive imaging cameras for ROP screening in developing countries.
- Hospital for Special Surgery (New York)minorResearch collaboration with Fan Zhang, PhD's lab at CU Anschutz. Researcher Laura Donlin, PhD from Hospital for Special Surgery collaborates on integrating single-cell spatial transcriptomics with AI methods to study rheumatoid arthritis therapeutic strategies.
- Colorado Department of Human ServicescorePartner with state agency through Colorado Statewide Falls Coalition to bring together experts and community members to address falls and provide resources. Aims to serve all Colorado counties through Area Agencies on Aging partnerships.
- Area Agencies on Aging (Colorado)core10 partner groups across Colorado counties deliver fall prevention programs including A Matter of Balance, Stepping On, and CAPABLE. These partners provide training, outreach, and support services such as transportation, home care, and meals.
- Children's Hospital ColoradocoreMajor pediatric hospital partner and COMIRB affiliate for human subjects research. Site for neonatal care, ROP screening, and pediatric clinical trials. Part of the Colorado Multiple Institutional Review Board oversight.
- UCHealthcorePrimary academic health system partner for clinical care, research, and education. Serves over 600,000 ED patients annually. Electronic health records system integrates automatic fall risk referrals to prevention programs.
- Denver Health and Hospital AuthorityminorSafety-net hospital partner and COMIRB affiliate for human subjects research. Part of the Colorado Multiple Institutional Review Board oversight covering CU Anschutz | CU Denver and affiliates.
- VA Eastern Colorado Health Care SystemminorVeterans healthcare system partner and COMIRB affiliate for clinical research. Part of the Colorado Multiple Institutional Review Board oversight covering CU Anschutz | CU Denver and affiliates.
Scale indicators8 records
Recent moves6 records
Expansion highlights5 records
University of Colorado Cancer Center competitors and assessment
Company assessmentDirect peers
- Mayo Clinic Comprehensive Cancer Center: Multi-site NCI Comprehensive Cancer Center with integrated research and clinical practice across oncology subspecialties. Directly comparable in translational pipeline and comprehensive clinical model.
- MD Anderson Cancer Center: One of the original NCI-designated Comprehensive Cancer Centers and the global benchmark for translational oncology. Directly comparable to CU Cancer Center in NCI designation status, clinical-trial volume, and bench-to-bedside pipeline focus.
- Memorial Sloan Kettering Cancer Center: NCI-designated Comprehensive Cancer Center with overlapping clinical, research, and training programs, including pioneering work in CAR T-cell therapy. Directly comparable on translational research intensity and oncology clinical volume.
- Dana-Farber Cancer Institute: Harvard-affiliated NCI Comprehensive Cancer Center with parallel research, clinical trials, and AI-driven precision oncology programs. Comparable in faculty scale, NIH funding profile, and integration with a major teaching hospital.
- UCSF Helen Diller Family Comprehensive Cancer Center: UCSF's NCI Comprehensive Cancer Center, comparable in NCI designation, AI/computational oncology research, and clinical-trial breadth at an academic medical center.
- Stanford Cancer Institute: NCI-designated cancer center at Stanford School of Medicine with similar AI/ML and precision-medicine investments. Comparable as an academic-medical-center-embedded cancer research enterprise.
- Fred Hutchinson Cancer Center: UW-affiliated NCI Comprehensive Cancer Center with deep expertise in bone marrow transplantation, immunotherapy, and translational research. Comparable research scope and academic medical center integration model.
- Sidney Kimmel Cancer Center at Johns Hopkins: Johns Hopkins' NCI Comprehensive Cancer Center with comparable translational research depth, CAR T-cell and immunotherapy work, and academic medical center integration.
- University of Michigan Rogel Cancer Center: Midwestern NCI Comprehensive Cancer Center with comparable research funding scale, multi-hospital partnerships, and translational/clinical trial programs.
Broad incumbents
- University of Colorado Anschutz Medical Campus: Parent AMC of the CU Cancer Center. The broader campus houses the School of Medicine, College of Nursing, School of Pharmacy, School of Public Health, and Dental Medicine, and is the relevant comparator for institutional-scale operating and research metrics.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
University of Colorado Cancer Center social profiles
Digital presenceUniversity of Colorado Cancer Center compliance and trust
Trust signalCompliance4 records
University of Colorado Cancer Center financial estimates
Financial estimateRevenue estimate
Valuation estimate
University of Colorado Cancer Center leadership team
Management profileNumber of profiles
University of Colorado Cancer Center funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
University of Colorado Cancer Center M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about University of Colorado Cancer Center
What does University of Colorado Cancer Center do?
The University of Colorado Cancer Center is an NCI-designated Comprehensive Cancer Center providing cancer diagnosis, treatment, and clinical trials to patients, alongside biomedical research and medical education programs. It operates as part of the CU Anschutz Medical Campus and is affiliated with UCHealth, Children's Hospital Colorado, Denver Health, and VA Eastern Colorado, conducting translational research, AI-driven diagnostics, and innovative therapies including FDA-cleared CAR T-cell therapy.
Is University of Colorado Cancer Center a public or private company?
University of Colorado Cancer Center is a private company. It is classified as state government owned and is currently operating.
When was University of Colorado Cancer Center founded?
University of Colorado Cancer Center was founded in 1988. It employs 10,001+ people.
Where is University of Colorado Cancer Center based?
University of Colorado Cancer Center is headquartered in Aurora, United States, in the North America region.
How does University of Colorado Cancer Center make money?
Three revenue lines are on record. Research Grants and Funding is the primary driver. The others are patient Care Services and education and Training Programs.
Who are University of Colorado Cancer Center's main competitors?
Direct peers on record are Mayo Clinic Comprehensive Cancer Center, MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center, Dana-Farber Cancer Institute, UCSF Helen Diller Family Comprehensive Cancer Center, Stanford Cancer Institute, Fred Hutchinson Cancer Center, Sidney Kimmel Cancer Center at Johns Hopkins and University of Michigan Rogel Cancer Center. University of Colorado Anschutz Medical Campus is listed as a broad incumbent.
Does University of Colorado Cancer Center have an API?
No public API is recorded for University of Colorado Cancer Center.
What industry is University of Colorado Cancer Center in?
University of Colorado Cancer Center's product category is Cancer Treatment and Research. Its primary akta.pro industry code is HLAFAAAA, Academic Medical Centers (AMCs) & Teaching Hospitals, with a secondary code of HLAFAAAM, Hospital-Integrated Cancer Centers (Acute Oncology Programs). Its NAICS code is 622310 and its SIC code is 8011.